Cargando…
PD-L1 Expression in Medullary Thyroid Carcinoma and Its Association with Clinicopathological Findings
Objective: Medullary thyroid carcinoma (MTC) is a rare tumor originating from parafollicular C cells. It has more aggressive biologic behavior than differentiated thyroid carcinomas, and it is insensitive to treatment with radioactive iodine. Vandetanib and cabozantinib are the newly approved tyros...
Autores principales: | Kemal, Yasemin, Caliskan, Sultan, Gun, Seda, Kefeli, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of Turkish Pathology Societies
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999690/ https://www.ncbi.nlm.nih.gov/pubmed/34580845 http://dx.doi.org/10.5146/tjpath.2021.01558 |
Ejemplares similares
-
Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies
por: Calıskan, Sultan, et al.
Publicado: (2023) -
Very low expression of PD-L1 in medullary thyroid carcinoma
por: Bongiovanni, Massimo, et al.
Publicado: (2017) -
Expression of PD‐L1 in medullary thyroid carcinoma—a new therapeutic target?
por: Fonseca, Liliana, et al.
Publicado: (2021) -
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
por: Bai, Yanhua, et al.
Publicado: (2017) -
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
por: Moura, M M, et al.
Publicado: (2009)